Lido Advisors
VANI icon

Lido Advisors’s Vivani Medical VANI Stock Holding History

Lido Advisors’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-500
Closed -$9K – 678
2019
Q4 		$9K Hold
500
– – ﹤0.01% 652
2019
Q3 		$10K Hold
500
– – ﹤0.01% 572
2019
Q2 		$9K Buy
+500
New +$10.3K ﹤0.01% 535

Other funds holding VANI

VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WA
WealthTrust Axiom Wayne, Pennsylvania $448M AUM 50.36% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.9B AUM 23.65% 1-Year Est. Return

Lido Advisors's VANI Position: Q1 2020 in Review

Lido Advisors sold out of Vivani Medical (VANI) in Q1 2020, closing a stake of 500 shares — an estimated $9K sold.

Lido Advisors first reported a position in VANI in Q2 2019 and held it in 3 quarters. The position peaked at $10K in Q3 2019. 21 funds tracked by Wall St. Rank hold VANI as of Q1 2020.

  • Lido Advisors reported no remaining Vivani Medical position as of Q1 2020 after selling out during the quarter.
  • Lido Advisors sold 500 Vivani Medical shares in Q1 2020, an estimated $9K.
  • Lido Advisors first reported a position in Vivani Medical in Q2 2019 and held it in 3 quarters.
  • Lido Advisors's Vivani Medical position peaked at $10K in Q3 2019.
  • 21 funds tracked by Wall St. Rank held Vivani Medical as of Q1 2020.

Based on Lido Advisors's 13F filing for Q1 2020, filed 13 May 2020.